Metilfenidato y fenómeno de Raynaud secundario

  1. Iglesias Otero, María
  2. Portela Romero, Manuel
  3. Bugarín González, Rosendo
  4. Ventura Victoria, Maria Antonia
Semergen: revista española de medicina de familia

ISSN: 1138-3593

Year of publication: 2013

Issue: 6

Pages: 330-334

Type: Article


More publications in: Semergen: revista española de medicina de familia

Sustainable development goals


Raynaud's phenomenon is a clinical disease characterized by episodic attacks of vasoconstriction of the arteries and arterioles of the extremities such as fingers and toes, sometimes the ears and nose, in response to cold or emotional stimuli. A classic attack is the pallor of the distal extremity, followed by cyanosis and redness, accompanied by paresthesia, usually as heat. When it occurs without apparent cause is called primary Raynaud's phenomenon. When associated with other disease, is called secondary Raynaud's phenomenon. The secondary table is associated with increased frequency of rheumatic diseases of collagen. They can also present certain drugs that cause vasoconstriction, such as ergotamine, beta-adrenergic antagonists, contraception and sympathomimetic drugs. Regarding the latter, we present a case of Raynaud's phenomenon secondary to methylphenidate in a 14 years.